ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells

被引:9
作者
Yi-Chang Cheng
Wei-Wen Kuo
Hsi-Chin Wu
Tung-Yuan Lai
Chun-Hsien Wu
Jin-Ming Hwang
Wen-Hong Wang
Fuu-Jen Tsai
Jaw-Ji Yang
Chih-Yang Huang
Chun-Hsien Chu
机构
[1] China Medical University Hospital,Emergency Department
[2] China Medical University,Department of Biological Science and Technology
[3] China Medical University Hospital,School of Medicine
[4] China Medical University,Post
[5] Chung-Shan Medical University,Baccalaureate School of Chinese Medicine
[6] Taichung Veterans General Hospital,School of Applied Chemistry
[7] China Medical University,Department of Nutrition
[8] Chung-Shan Medical University,Department of Pediatrics, Medical Research and Medical Genetics
[9] China Medical University,School of Dentistry
[10] China Medical University,Graduate Institute of Chinese Medical Science
[11] Asia University,Graduate Institute of Basic Medical Science
来源
Molecular and Cellular Biochemistry | 2009年 / 325卷
关键词
ZAK (mixed lineage protein kinase, Leucine-zipper, and sterile-alpha motif kinase); MMP-2/9; TIMP-1/2 and cardiac fibrosis;
D O I
暂无
中图分类号
学科分类号
摘要
Leucine-zipper and sterile-alpha motif kinase (ZAK) is the key intra-cellular mediator protein in cardiomyocyte hypertrophy induction by transforming growth factor beta 1 (TGF-β1) which has also been identified as a profibrotic cytokine involved in cardiac fibrosis progression. We hypothesized whether ZAK over-expression causes cardiac scar formation due to the extra-cellular matrix (ECM) degraded enzyme regulation in this paper. Using immuno-histochemical analysis of the human cardiovascular tissue array, we found a positively significant association between ZAK over-expression and myocardial scars. ZAK over-expression in H9c2 cardiomyoblast cells increases the metalloproteinase tissue inhibitor 1/2 (TIMP-1/2) protein level, which reduces matria metalloproteinase-9 (MMP-9) activity and also activates c-JNK N-terminal kinase 1/2 (JNK1/2) and p38 signaling, which induces MMP-2, possibly resulting in cardiac fibrosis. Taken together, ZAK activity inhibition may be a good strategy to prevent the cardiac fibrosis progression.
引用
收藏
页码:69 / 77
页数:8
相关论文
共 189 条
[1]
Vasan RS(2001)Diastolic heart failure—no time to relax N Engl J Med 344 56-59
[2]
Benjamin EJ(1989)Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle Circ Res 64 1041-1050
[3]
Jalil JE(2007)ECM remodeling in hypertensive heart disease J Clin Invest 117 568-575
[4]
Doering CW(2002)Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction J Card Fail 8 S344-S348
[5]
Janicki JS(2000)MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition Cardiovasc Res 46 298-306
[6]
Pick R(2000)Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling Cardiovasc Res 46 214-224
[7]
Shroff SG(2005)The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat J Mol Cell Cardiol 38 193-204
[8]
Weber KT(2004)Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury Trends Cardiovasc Med 14 196-202
[9]
Berk BC(2000)A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure Circulation 102 1944-1949
[10]
Fujiwara K(2005)Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure J Cell Mol Med 9 704-713